These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11268464)

  • 41. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
    Dai N; Bao Q; Lu A; Li J
    Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
    Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
    Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical results of early gastric cancer and proposing a treatment strategy.
    Lo SS; Wu CW; Chen JH; Li AF; Hsieh MC; Shen KH; Lin HJ; Lui WY
    Ann Surg Oncol; 2007 Feb; 14(2):340-7. PubMed ID: 17094028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative recurrence in gastric cancer: analysis of 59 cases.
    Peng CW; Li Y; Yang GL; Xiong B; Feng MH; Cheng FL
    Hepatogastroenterology; 2010; 57(99-100):663-7. PubMed ID: 20698246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.
    Cascinu S; Graziano F; Valentini M; Catalano V; Giordani P; Staccioli MP; Rossi C; Baldelli AM; Grianti C; Muretto P; Catalano G
    Ann Oncol; 2001 Feb; 12(2):239-44. PubMed ID: 11300331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer.
    Kim JW; Cho HJ; Kim M; Lee KH; Kim MA; Han SW; Oh DY; Lee HJ; Im SA; Kim TY; Yang HK; Kim WH; Bang YJ
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1435-43. PubMed ID: 23633032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma.
    Gustafson P; Baldetorp B; Fernö M; Akerman M
    Br J Cancer; 1999 Mar; 79(7-8):1205-9. PubMed ID: 10098760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.